Form 8-K - Current report:
SEC Accession No. 0001708599-26-000027
Filing Date
2026-04-21
Accepted
2026-04-21 17:12:23
Documents
12
Period of Report
2026-04-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Document Format Files

Seq Description Document Type Size
1 8-K ser-20260415.htm   iXBRL 8-K 28219
2 EX-3.1 ex31-changexproredlinexser.htm EX-3.1 272234
  Complete submission text file 0001708599-26-000027.txt   550581

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ser-20260415.xsd EX-101.SCH 1800
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ser-20260415_lab.xml EX-101.LAB 54435
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ser-20260415_pre.xml EX-101.PRE 31811
15 EXTRACTED XBRL INSTANCE DOCUMENT ser-20260415_htm.xml XML 2920
Mailing Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806
Business Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806 (256) 327-9630
Serina Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

EIN.: 821436829 | State of Incorp.: AL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38519 | Film No.: 26880513
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)